SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
This Quarter Return
+2.86%
1 Year Return
+41.48%
3 Year Return
+28.47%
5 Year Return
+53.25%
10 Year Return
–
AUM
$8.31B
AUM Growth
+$8.31B
(+3.4%)
Cap. Flow
+$57.7M
Cap. Flow
% of AUM
0.69%
Top 10 Holdings %
Top 10 Hldgs %
21.74%
Holding
291
New
12
Increased
68
Reduced
154
Closed
16
Top Buys
| 1 |
DuPont de Nemours
DD
|
$149M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
$62.5M |
| 3 |
Pfizer
PFE
|
$28.2M |
| 4 |
Eaton
ETN
|
$23.6M |
| 5 |
MetLife
MET
|
$20.1M |
Top Sells
| 1 |
DD
Du Pont De Nemours E I
DD
|
$141M |
| 2 |
Boeing
BA
|
$81M |
| 3 |
JPMorgan Chase
JPM
|
$26.4M |
| 4 |
UN
Unilever NV New York Registry Shares
UN
|
$16.1M |
| 5 |
Manulife Financial
MFC
|
$11.8M |
Sector Composition
| 1 | Financials | 15.28% |
| 2 | Healthcare | 13.04% |
| 3 | Industrials | 9.52% |
| 4 | Energy | 8.89% |
| 5 | Technology | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novartis
NVS
$245B
| $227M | 2.73% | 2,643,971 -136,635 | -5% | -$11.7M |
|
|
UN
2
DELISTED
Unilever NV New York Registry Shares
UN
| $217M | 2.61% | 3,676,705 -272,747 | -7% | -$16.1M |
|
|
RDS.B
3
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $195M | 2.34% | 3,110,782 -118,848 | -4% | -$7.43M |
|
4
HSBC
HSBC
$224B
| $190M | 2.29% | 3,847,229 -117,964 | -3% | -$5.83M |
|
5
BCE
BCE
$23.3B
| $172M | 2.08% | 3,683,295 -76,760 | -2% | -$3.59M |
|
6
Diageo
DEO
$62.1B
| $163M | 1.96% | 1,229,860 -5,948 | -0.5% | -$786K |
|
|
SI
7
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $162M | 1.95% | 2,293,420 +882,806 | +63% | +$62.5M |
|
8
Johnson & Johnson
JNJ
$427B
| $162M | 1.95% | 1,247,650 -26,002 | -2% | -$3.38M |
|
9
Cisco
CSCO
$274B
| $160M | 1.92% | 4,745,965 -167,148 | -3% | -$5.62M |
|
10
Microsoft
MSFT
$3.77T
| $158M | 1.91% | 2,126,952 -72,382 | -3% | -$5.39M |
|
11
Chevron
CVX
$324B
| $157M | 1.89% | 1,332,768 -35,231 | -3% | -$4.14M |
|
12
Chubb
CB
$110B
| $154M | 1.86% | 1,083,552 -26,686 | -2% | -$3.8M |
|
|
13
JPMorgan Chase
JPM
$829B
| $152M | 1.84% | 1,596,320 -276,160 | -15% | -$26.4M |
|
|
14
Pfizer
PFE
$141B
| $152M | 1.82% | 4,244,688 +789,462 | +23% | +$28.2M |
|
15
AstraZeneca
AZN
$248B
| $150M | 1.81% | 4,430,147 +217,883 | +5% | +$7.38M |
|
|
16
DuPont de Nemours
DD
$32.2B
| $149M | 1.79% | +2,152,421 | New | +$149M |
|
17
Welltower
WELL
$113B
| $147M | 1.76% | 2,085,814 -9,729 | -0.5% | -$684K |
|
18
Merck
MRK
$210B
| $144M | 1.73% | 2,246,974 +65,327 | +3% | +$4.18M |
|
19
AT&T
T
$209B
| $141M | 1.69% | 3,591,650 -101,941 | -3% | -$3.99M |
|
|
20
MetLife
MET
$54.1B
| $135M | 1.63% | 2,600,107 +387,706 | +18% | +$20.1M |
|
21
Wells Fargo
WFC
$263B
| $135M | 1.63% | 2,448,571 -31,970 | -1% | -$1.76M |
|
22
NextEra Energy, Inc.
NEE
$148B
| $133M | 1.6% | 904,388 -29,633 | -3% | -$4.34M |
|
23
Travelers Companies
TRV
$61.1B
| $124M | 1.5% | 1,014,861 -13,743 | -1% | -$1.68M |
|
24
Altria Group
MO
$113B
| $123M | 1.48% | 1,937,484 -92,707 | -5% | -$5.88M |
|
|
RTN
25
DELISTED
Raytheon Company
RTN
| $121M | 1.46% | 649,412 -24,690 | -4% | -$4.61M |
|